VYCOR MEDICAL, INC.

VYCO
Delayed Quote. Delayed  - 08/07 02:50:10 pm
0.352USD +2.03%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Net sales1 1,251,141,451,381,511,48
EBITDA1 -2,35-1,62-1,32-1,02-0,83-0,66
Operating profit (EBIT)1 -2,73-1,99-1,59-1,31-1,01-0,73
Operating Margin -219%-175%-110%-94,8%-66,9%-48,9%
Pre-Tax Profit (EBT)1 -4,05-2,08-1,65-1,48-1,38-0,80
Net income1 -4,05-2,08-1,65-1,48-1,38-0,80
Net margin -324%-183%-114%-107%-91,4%-53,7%
EPS2 -0,39-0,21-0,17-0,10-0,08-0,05
Dividend per Share ------
Last update 11/08/201603/31/201703/30/201803/29/201903/27/202003/27/2020
1 USD in Million
2 USD
Finances - Leverage
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Net Debt1 --0,510,110,430,51
Net Cash position1 1,570,03----
Leverage (Debt / EBITDA) 0,67x0,02x-0,38x-0,11x-0,52x-0,78x
Free Cash Flow1 -3,13-0,800,320,000,170,57
ROE (Net Profit / Equities) 1 900%-103%-295%-5 371%401%75,0%
Shareholders' equity1 -0,212,020,560,03-0,34-1,06
ROA (Net Profit / Asset) -57,6%-42,6%-56,7%-55,9%-50,6%-42,4%
Assets1 7,034,882,912,642,721,88
Book Value Per Share2 0,270,100,000,00-0,03-0,05
Cash Flow per Share2 0,180,030,010,010,000,00
Capex1 0,130,210,060,180,060,06
Capex / Sales 10,5%18,4%3,95%13,2%4,21%3,93%
Last update 11/08/201603/31/201703/30/201803/29/201903/27/202003/27/2020
1 USD in Million
2 USD
Balance Sheet Analysis
Price Earning Ratio
EPS & Dividend